Trending Stocks: Pointer Telocation Ltd. (NASDAQ:PNTR), Evoke Pharma, Inc. (NASDAQ:EVOK), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), Entegris, Inc. (NASDAQ:ENTG)

Pointer Telocation Ltd. (NASDAQ:PNTR) belongs to Technology sector. Its net profit margin is 13.50% and weekly performance is -8.52%. On last trading day company shares ended up $7.30. Pointer Telocation Ltd. (NASDAQ:PNTR) distance from 50-day simple moving average (SMA50) is -11.59%. Zacks cut shares of Pointer Telocation (NASDAQ:PNTR) from a strong-buy rating to a hold rating in a research note issued to investors on Tuesday, Analyst Ratings.Net reports.

Evoke Pharma, Inc. (NASDAQ:EVOK) shares fell -2.88% in last trading session and ended the day at $6.07. EVOK return on assets is -94.00%. Evoke Pharma, Inc. (NASDAQ:EVOK) quarterly performance is -22.68%. Evoke Pharma, Inc. (NASDAQ:EVOK), hosted an investor presentation on Wednesday, July 8, 2015 at 10:15 AM ET at the Cantor Fitzgerald Inaugural Healthcare Conference. The conference held on July 8, 2015 at Le Parker Meridien Hotel in New York City.

On 14 July, TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) shares increased 0.18% and was closed at $2.81. TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) year to date (YTD) performance is -41.70%. On 29 June, TetraLogic Pharmaceuticals Corporation (NASDAQ: TLOG) announced preliminary data from the ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes (MDS).

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) ended the last trading day at $67.55. Company weekly volatility is calculated as 3.85% and price to cash ratio as 15.89. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) showed a weekly performance of -1.65%. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) announced that financial results for the company’s second quarter ended June 30, 2015 will be released before the market opens on Thursday, July 30, 2015. The Pacira management team will host a conference call to discuss the company’s financial results and recent and upcoming developments on Thursday, July 30, 2015, at 9 a.m. ET.

Entegris, Inc. (NASDAQ:ENTG) shares remains unchanged in last trading session and ended the day at $13.90. ENTG Gross Margin is 39.80% and its return on assets is 0.50%. Entegris, Inc. (NASDAQ:ENTG) quarterly performance is 0.29%. Entegris, Inc. (NASDAQ:ENTG) announced the release of Torrento® X Series 7 nm filters with FlowPlane™ linear filtration technology. FlowPlane is the semiconductor industry’s first scalable, linear, high-flow filtration platform enabling advanced wet cleaning applications for the 10 nm node and beyond. The first in a series of filters based on the linear filtration technology, the FlowPlane S model is designed for point of dispense (POD) applications, enabling improvements in both on-wafer defectivity and yield for critical wet cleaning applications.

Leave a Reply

Your email address will not be published. Required fields are marked *